Prolactin and cyclosporine modulate adenosine transporters and adenosine A1 receptors in the rat brain

Journal of Physiology and Biochemistry

Volumn 56, Issue 2, 2000, Pages 83-90

  Fideu, M D ^b   Arce, A ^b   Miras Portugal, M T ^b   Esquifino, Ana Isabel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b NONE

Author keywords

Adenosine; Central nervous system; Cyclosporine; Prolactin

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; CYCLOSPORIN A; NITROBENZYLTHIOINOSINE; PROLACTIN;

ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HYPERPROLACTINEMIA; MALE; NONHUMAN; PROLACTIN BLOOD LEVEL; RAT; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION;

EID: 0033856944     PISSN: 11387548     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03179903     Document Type: Article

References (44)

1. Ingulli, E., González, R., Rajport, D., Pomratz, A., Sumrai, N., Hong, J., Butt, K. N. H. and Tejani, A. (1989): Child. Nephrol. Urol., 9, 312-318.
2. Handelsmann, D. J., McDowell, I. F. W., Caterson, I.D., Tiller, D., Hall, B.M. and Turtle, J. R. (1984): Clin. Nephrol., 22,144-148.
3. Ramírez, G., Navarte, J., Bittle, P. A., Ayers-Chastain, C. and Dean, S.E. (1991): Nephron, 58, 27-32.
4. Sika, S. C., Bhasin, S., Coy, D. C., Koyle, M. A., Swerdloff, R.S. and Rafjer, J. (1989): Endocrinology, 123, 283-287.
5. Esquifino, A. I., Moreno, M. L., Arce, A., Agrasal, C., Perez-Díaz, J. and Villanúa, M. A. (1995): J. Endocrinol., 144, 159-164.
6. Fernández-Ruiz, J., Cebeira, M., Agrasal, C., Tresguerres, J. A. F., Bartke, A., Esquifino, A. I. and Ramos, J. A. (1987): J. Endocrinol., 113, 45-49.
7. Kalra, P. S., Simpkins, J. W. and Kalra, S. P. (1981): Neuroendocrinology, 33, 118-122.
8. Hohn, K. G. and Wuttke, W. D. (1978): Brain Res., 156, 241-252.
9. Clemens, J. A., Gallo, R. V., Whitmoyer, D. I. and Sawyer, C.H. (1971): Brain Res., 25, 371-379.
10. Poulain, P. and Carette, B. (1976): Brain Res., 116, 172-176.
11. Linden, J. (1991): FASEB J.; 5, 2668-2676.
12. Wu, P. H. and Phillis, J. W. (1984): Neurochem. Int., 6, 613-632.
13. Myers, S. L., and Pusley, T. A. (1989): Pharmacologist, 26, 217-221.
14. Jabers, M., Robinson, S. W., Missale, C. and Caron, M. G. (1996): Neuropharmacol., 35, 1503-1519.
15. Fastbom, J. and Fredholm, B. B. (1990): Neuroscience, 34, 759-769.
16. Phillis, J. W. and Wu, P. H. (1981): Prog. Neurobiol., 116, 187-239.
17. Chern, Y. J., Herrera, M., Kao, L. S. and Westhead, E. W. (1987): J. Neurochem., 48, 1573-1576.
18. Fernández-Ruiz, J., Cebeira, M., Agrasal, C., Tresguerres, J. A. F., Esquifino, A.I. and Ramos, J. A. (1987): Neuroendocrinology, 45, 208-211.
19. Moreno, M. L., Villanúa, M. A., Galaz, C., Navarro, P. and Esquifino, A. I. (1991): Pflügers Arch., 12, 162.
20. Fideu, M. D. and Miras-Portugal, M. T. (1993): Mol .Cell Neurobiol., 13, 493-501.
21. Fideu, M. D., Arce, A., Esquifino, A. I. and Miras-Portugal, M. T. (1994): Am. J. Physiol., 267, C1651-C1656.
22. Tresguerres, J. A. F. and Esquifino, A. I. (1981): J. Endocrinol., 90, 41-51.
23. Oliveira, J. C., Sebastiao, A. M. and Ribeiro, J. A. (1991): J. Neurochem., 57, 1165-1171.
24. Esquifino, A. I., Moreno, M. L., Agrasal, C. and Villanúa, M. A. (1995): Proc. Soc. Exptl. Biol. Med., 208, 397-403.
25. Ploeg, I., Parkinson, F. E. and Fredholm, B. B. (1992): J. Neurochem., 58, 1221-1229.
26. Bartke, A. and Shrenker, P. (1987): Crit. Rev. Anat. Sci., 1, 37-62.
27. Villanúa, M. A., Szary, A., Bartke, A. and Esquifino, A. I. (1992): Prog. Neuroendocrinimmunol., 5, 40-51.
28. Davenport, A. T. and Hodson, C. A. (1992). Life Sci., 50, 1001-1006.
29. Lafuente, A., Salgado, A., García-Bonacho, A. and Esquifino, A. I. (1996): J. Neuroimmunol., 65, 41-47.
30. Esquifino, A. I., González, M. E. and Lafuente, M. A. (1996): Proc. Soc. Exptl. Biol. Med., 213, 206-211.
31. Moreno, M. L., Villanúa, M. A., Arce, A. and Esquifino, A. I.. (1995): J. Neuroendocrinol., 7, 765-774.
32. Villanúa, M. A., Szary, A., Bartke, A. and Esquifino, A. I. (1992): Prog. Neuroendocrinol., 5, 40-51.
33. Villanúa, M. A., Steger, R. W., Szary, A., Esquifino, A. I. and Bartke, A. (1992): Prog. Neuroendocrinol., 5, 40-51.
34. Nicoletti, F., Canonico, P., Patti, F., Rampelo, L., Condorelli, D. F., Giammona, G., di Giorgio, R. M. and Scapagnini, U. (1982): Eur. J. Pharmacol., 77, 131-135.
35. Lee, K. S., Tetzlaff, W. and Kreutzberg, G. W. (1986): Brain Res., 380, 155-158.
36. Fredholm, B. B. (1982): Acta Physiol. Scand., 115, 283-286.
37. Murray, T. F. (1982): Eur. J. Pharmacol., 82, 113-114.
38. Barrie, A. P. and Nicholls, D. G. (1993): J. Neurochem., 60, 1081-1086.
39. Mansky, T., Duker, E. and Wuttke, W. (1983): Neurosci. Lett., 39, 267-272.
40. Kolbinger, W., Beyer, C., Fohr, K., Reisert, I. and Pilgrim, C. (1992): Neuroendocrinology, 56, 148-152.
41. Yawo, H. and Chuhma, N. (1993): Nature, 365, 256-258.
42. Schreiber, S. L. (1991): Science, 251, 283-287.
43. LeGrue, S.J. and Munn, C. G. (1986): Transplantation, 42, 679-685.
44. Galat, A. (1993): Eur. J. Biochem., 216, 689-707.